Top ▲
GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
Gene and Protein Information ![]() |
||||||
class A G protein-coupled receptor | ||||||
Species | TM | AA | Chromosomal Location | Gene Symbol | Gene Name | Reference |
Human | 7 | 319 | 6q27 | GPR31 | G protein-coupled receptor 31 | 7 |
Mouse | 7 | 319 | 17 A1 | Gpr31c | G protein-coupled receptor 31, D17Leh66c region | |
Rat | 7 | 319 | 1q11 | Gpr31 | G protein-coupled receptor 31 |
Previous and Unofficial Names ![]() |
12-HETER | HETER1 | hydroxyeicosatetraenoic (HETE) acid receptor 1 | 12-(S)-HETE acid receptor | G protein-coupled receptor 31, D17Leh66c region |
Database Links ![]() |
|
Specialist databases | |
GPCRdb | gpr31_human (Hs), gpr31_mouse (Mm) |
Other databases | |
Alphafold | O00270 (Hs), F8VQN3 (Mm) |
ChEMBL Target | CHEMBL4523859 (Hs) |
Ensembl Gene | ENSG00000120436 (Hs), ENSMUSG00000117239 (Mm), ENSRNOG00000039255 (Rn) |
Entrez Gene | 2853 (Hs), 667359 (Mm), 292310 (Rn) |
Human Protein Atlas | ENSG00000120436 (Hs) |
KEGG Gene | hsa:2853 (Hs), mmu:667359 (Mm), rno:292310 (Rn) |
OMIM | 602043 (Hs) |
Pharos | O00270 (Hs) |
RefSeq Nucleotide | NM_005299 (Hs), NM_001169132 (Rn) |
RefSeq Protein | NP_005290 (Hs), NP_001162603 (Rn) |
UniProtKB | O00270 (Hs), F8VQN3 (Mm) |
Wikipedia | GPR31 (Hs) |
Natural/Endogenous Ligands ![]() |
12S-HETE |
Comments: Proposed ligand, single publication |
Download all structure-activity data for this target as a CSV file
Agonists | ||||||||||||||||||||||||||||||||||||||
Key to terms and symbols | View all chemical structures | Click column headers to sort | ||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||
Agonist Comments | ||||||||||||||||||||||||||||||||||||||
12-(S)-HETE is a 12-lipoxygenase metabolite of arachidonic acid, which produces a number of cellular responses including cytoskeletal remodeling to facilitate cell chemotaxis and secretion of proteinases and vascular endothelial growth factor leading to an angiogenic response. 12-(S)-HETE treatment of cancer cells alsoenhanced the expression of integrins and fibronectin,which prolong cell survival. GPR31 displayed high affinity binding for tritiated 12-(S)-HETE (Kd = 5 nM) and unlabeled 12-(S)-HETE stimulated GTPγS coupling in the membranes of GPR31-transfected cells, with an EC50 of 0.28 nM [2]. In concordance, GPR31 is phylogenetically closest to the OXE receptor (for which the ligand is 5-oxo-6,8,11,14-eicosatetraenoic acid) [1]. Unlabelled 12S-HETE effectively replaces the radioactive ligand bound to receptors, whereas 12R-HETE is unable to replace GPR31 bound 12S-[3H]HETE suggesting stereospecific binding [2]. |
Immuno Process Associations | ||||||||||||
|
||||||||||||
|
Primary Transduction Mechanisms ![]() |
|
Transducer | Effector/Response |
Gi/Go family | |
Comments: 12S-HETE/GPR31 mediated ERK1/2 activation is inhibited by pertussis toxin, suggesting the involvement of Gi/o heterotrimeric G proteins [2] | |
References: 2 |
Expression Datasets ![]() |
|
|
Physiological Functions Comments | |
Thought to exert an effect on innate immunity through cytokine IFN-γ [4], [6]. |
Physiological Consequences of Altering Gene Expression Comments | |
Knockdown of GPR31 using shRNA in transfected CHO cells diminishes specific binding of 12S-[3H]HETE [2]. |
Clinically-Relevant Mutations and Pathophysiology Comments |
Dominantly inherited cutaneous small-vessel lymphocytic vasculitis maps to chromosome 6q26-q27, making GPR31 (which also maps to the linked region) a plausible candidate for the disease based on biological function [6]. |
Biologically Significant Variants ![]() |
||||||||||||||||||
|
||||||||||||||||||
Biologically Significant Variant Comments | ||||||||||||||||||
An in-frame 210-bp deletion in GPR31 is observed in the mouse t complex responder locus responsible for transmission ratio distortion of mouse t haplotypes [5]. |
General Comments |
Clone AK036897 holds 50% identity with human GPR31 indicating that it may be a murine paralog of the receptor. However it is too short to encode a putative GPCR structure, indicating that the cDNA is likely to be a partial fragment [3]. 12S-[3H]HETE has been shown to bind to the BLT2 receptor with much lower affinity than that of GPR31. |
1. Gloriam DE, Fredriksson R, Schiöth HB. (2007) The G protein-coupled receptor subset of the rat genome. BMC Genomics, 8: 338. [PMID:17892602]
2. Guo Y, Zhang W, Giroux C, Cai Y, Ekambaram P, Dilly AK, Hsu A, Zhou S, Maddipati KR, Liu J et al.. (2011) Identification of the orphan G protein-coupled receptor GPR31 as a receptor for 12-(S)-hydroxyeicosatetraenoic acid. J Biol Chem, 286 (39): 33832-40. [PMID:21712392]
3. Kawasawa Y, McKenzie LM, Hill DP, Bono H, Yanagisawa M, RIKEN GER Group, GSL Members. (2003) G protein-coupled receptor genes in the FANTOM2 database. Genome Res, 13 (6B): 1466-77. [PMID:12819145]
4. Schaub A, Fütterer A, Pfeffer K. (2001) PUMA-G, an IFN-gamma-inducible gene in macrophages is a novel member of the seven transmembrane spanning receptor superfamily. Eur J Immunol, 31 (12): 3714-25. [PMID:11745392]
5. Schimenti JC. (1999) ORFless, intronless, and mutant transcription units in the mouse t complex responder (Tcr) locus. Mamm Genome, 10 (10): 969-76. [PMID:10501965]
6. Sellick GS, Coleman RJ, Webb EL, Chow J, Bevan S, Rosbotham JL, Houlston RS. (2005) Dominantly inherited cutaneous small-vessel lymphocytic vasculitis maps to chromosome 6q26-q27. Hum Genet, 118 (1): 82-6. [PMID:16133183]
7. Zingoni A, Rocchi M, Storlazzi CT, Bernardini G, Santoni A, Napolitano M. (1997) Isolation and chromosomal localization of GPR31, a human gene encoding a putative G protein-coupled receptor. Genomics, 42 (3): 519-23. [PMID:9205127]
Alexander SP, Battey J, Benson HE, Benya RV, Bonner TI, Davenport AP, Dhanachandra Singh K, Eguchi S, Harmar A, Holliday N, Irving AJ, Jensen RT, Karnik S, Kostenis E, Liew WC, Monaghan AE, Mpamhanga C, Neubig R, Pawson AJ, Pin JP, Sharman JL, Spedding M, Spindel E, Stoddart L, Storjohann L, Thomas WG, Tirupula K, Vanderheyden P. Class A Orphans in GtoPdb v.2025.2. IUPHAR/BPS Guide to Pharmacology CITE. 2025; 2025(2). Available from: https://doi.org/10.2218/gtopdb/F16/2025.2.